VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,911,908 | -6.5% | 521,260 | +32.2% | 0.08% | -8.0% |
| Q2 2023 | $7,395,394 | +32.7% | 394,421 | +2.1% | 0.09% | +15.8% |
| Q1 2023 | $5,572,840 | -23.5% | 386,466 | +2.7% | 0.08% | -21.6% |
| Q4 2022 | $7,280,960 | -43.5% | 376,277 | +0.3% | 0.10% | -46.1% |
| Q3 2022 | $12,881,000 | +462.0% | 374,995 | +150.0% | 0.18% | +414.3% |
| Q2 2022 | $2,292,000 | -33.0% | 150,000 | 0.0% | 0.04% | -37.5% |
| Q1 2022 | $3,423,000 | -47.3% | 150,000 | -14.8% | 0.06% | -39.8% |
| Q4 2021 | $6,490,000 | -31.8% | 176,027 | -13.1% | 0.09% | -40.0% |
| Q3 2021 | $9,518,000 | -23.7% | 202,500 | -2.1% | 0.16% | -33.2% |
| Q2 2021 | $12,467,000 | – | 206,921 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |